In a groundbreaking projection released by Future Market Insights (FMI), the global proteomics market is on track to achieve a remarkable milestone, with anticipated demand expected to surpass USD 30, ...
The global physical therapy supplies market is experiencing remarkable growth, with projections indicating it will reach USD 16.3 billion in 2024. This upward trajectory is expected to continue, with ...
The global intraoperative radiation therapy systems market is poised for significant growth, with projections indicating a substantial increase in value over the next decade. According to recent ...
According to the latest report by Future Market Insights, the global hearing aids market is anticipated to witness a steady growth rate of 2.3% between 2024 and 2034. This projection comes amidst a ...
The global endoscope detergents and disinfectants market is set for remarkable expansion, with projections indicating a robust Compound Annual Growth Rate (CAGR) of 4.4% from 2022 to 2032. The market ...
The global facial erythema treatment market is witnessing significant expansion, driven by the increasing prevalence of facial redness and inflammation. According to recent market projections, the ...
The global hemostasis testing systems market is poised for substantial growth, with a projected value surge from USD 2,149.3 million in 2023 to USD 3,666 million by 2033. This anticipated expansion is ...
The global molecular cytogenetics market is poised for exceptional growth, with projections forecasting a substantial rise from USD 2,761.9 Million in 2022 to an impressive USD 6,469.2 Million by 2032 ...
In the ever-evolving landscape of cosmetic surgery, the global liposuction surgery devices market is making notable strides, showcasing transformative progress and innovation. As of 2023, the market ...
Novavax, Inc. (Nasdaq: NVAX), a global company advancing protein-based vaccines with its Matrix-M™ adjuvant, today announced ...
Pharma Contract Manufacturing 2025 is taking place in Berlin next March (26-27th). Download the event details here: Ahead of ...
Independent Data Safety Monitoring Board declared dose level 2 as safe and recommended escalation to final dose level 3Munich, ...